Condition or disease | Intervention/treatment |
---|---|
Clavicular Fractures | Procedure: Interscalene-Cervical Plexus Block Procedure: Supraclavicular-Cervical Plexus Block |
Study Type : | Observational |
Estimated Enrollment : | 150 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | Ultrasound-Guided Combined Interscalene-Cervical Plexus Versus Combined Supraclavicular-Cervical Plexus Block for Surgical Anesthesia in Clavicular Fractures: A Retrospective Observational Study |
Estimated Study Start Date : | May 1, 2019 |
Estimated Primary Completion Date : | December 1, 2021 |
Estimated Study Completion Date : | March 1, 2022 |
Group/Cohort | Intervention/treatment |
---|---|
Interscalene-Cervical Plexus Block
Ultrasound-Guided Combined Interscalene-Cervical Plexus Block
|
Procedure: Interscalene-Cervical Plexus Block
Ultrasound-Guided Combined Interscalene-Cervical Plexus Block
|
Supraclavicular-Cervical Plexus Block
Ultrasound-Guided Combined Supraclavicular-Cervical Plexus Block
|
Procedure: Supraclavicular-Cervical Plexus Block
Ultrasound-Guided Combined Supraclavicular-Cervical Plexus Block
|
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
Exclusion Criteria:
Contact: Ruizhao Lv, M.D | +86-17772657375 | lvruizhao@hotmail.com |
China, Hebei | |
Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine | |
Cangzhou, Hebei, China, 061001 |
Principal Investigator: | Ruizhao Lv, M.D | Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine |
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date | April 28, 2019 | ||||
First Posted Date | May 1, 2019 | ||||
Last Update Posted Date | May 9, 2019 | ||||
Estimated Study Start Date | May 1, 2019 | ||||
Estimated Primary Completion Date | December 1, 2021 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures |
Block success rate [ Time Frame: At time 15 minutes after the block ] Sensory blockade was assessed using the pinprick test at the surgery site
|
||||
Original Primary Outcome Measures | Same as current | ||||
Change History | |||||
Current Secondary Outcome Measures |
Acute complications [ Time Frame: At the end of surgery immediately ] Number of participants with phrenic nerve palsy
|
||||
Original Secondary Outcome Measures |
Acute complications [ Time Frame: At the end of surgery immediately ] Phrenic nerve palsy
|
||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title | Analgesia for Clavicular Fracture and Surgery | ||||
Official Title | Ultrasound-Guided Combined Interscalene-Cervical Plexus Versus Combined Supraclavicular-Cervical Plexus Block for Surgical Anesthesia in Clavicular Fractures: A Retrospective Observational Study | ||||
Brief Summary | Compared efficacy of ultrasound-guided combined interscalene-cervical plexus versus combined supraclavicular-cervical plexus block for surgical anesthesia in clavicular fractures. | ||||
Detailed Description | The primary objective of this study was to compare the effectiveness of ultrasound-guided combined interscalene-cervical plexus versus combined supraclavicular-cervical plexus block for surgical anesthesia in clavicular fractures.The hypothesis of this study was that the supraclavicular-cervical plexus block could provide better anesthesia with less anesthesia related complications. | ||||
Study Type | Observational | ||||
Study Design | Observational Model: Cohort Time Perspective: Retrospective |
||||
Target Follow-Up Duration | Not Provided | ||||
Biospecimen | Not Provided | ||||
Sampling Method | Probability Sample | ||||
Study Population | 150 | ||||
Condition | Clavicular Fractures | ||||
Intervention |
|
||||
Study Groups/Cohorts |
|
||||
Publications * | Not Provided | ||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status | Not yet recruiting | ||||
Estimated Enrollment |
150 | ||||
Original Estimated Enrollment | Same as current | ||||
Estimated Study Completion Date | March 1, 2022 | ||||
Estimated Primary Completion Date | December 1, 2021 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender |
|
||||
Ages | 18 Years to 65 Years (Adult, Older Adult) | ||||
Accepts Healthy Volunteers | Yes | ||||
Contacts |
|
||||
Listed Location Countries | China | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number | NCT03933228 | ||||
Other Study ID Numbers | 2019CZTCWM4 | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement | Not Provided | ||||
Responsible Party | Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine | ||||
Study Sponsor | Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine | ||||
Collaborators | Not Provided | ||||
Investigators |
|
||||
PRS Account | Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine | ||||
Verification Date | April 2019 |